Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
R-spondin 3 is a secreted protein encoded by the RSPO3 gene in humans. It is a member of the R-spondin family and functions as a positive modulator of Wnt/β-catenin signaling by binding to LGR4/5/6 receptors and regulating the internalization of Wnt co-receptors such as LRP6. This activity enhances Wnt pathway activation and stabilizes β-catenin. R-spondin 3 plays critical roles in embryonic development (notably vasculogenesis and angiogenesis), stem cell maintenance (notably expansion of Lgr5+ intestinal stem cells), tissue regeneration, fibrosis development in multiple organs (including liver and lung), oncogenesis (colorectal cancer via Wnt-dependent mechanisms; breast cancer via both Wnt-dependent and independent mechanisms), and modulation of inflammation after ischemic stroke. Recombinant forms are used extensively in research for organoid culture systems[1][2][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on R-spondin 3.